Effect of AC-3579, a diazafluoranthen derivative, on murine leukemia P388 and L1210--I. In vivo study.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001372:Aza Compounds / Q000627:therapeutic use; D005449:Fluorenes / Q000627:therapeutic use*; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000378:metabolism; D008099:Liver / Q000648:ultrastructure; D008223:Lymphoma / Q000188:drug therapy; D051379:Mice; D008854:Microscopy, Electron; D010710:Phosphates / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D010761:Phosphorus Radioisotopes; D010879:Piperazines / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D013936:Thymidine; D014316:Tritium
D001372:Aza Compounds; D005449:Fluorenes; D010710:Phosphates; D010743:Phospholipids; D010761:Phosphorus Radioisotopes; D010879:Piperazines; D014316:Tritium; C006177:2-(4'-methylpiperazino-1-methyl)-1,3-diazafluoranthene 1-oxide; D000251:Adenosine Triphosphatases; D013936:Thymidine